Form 483

Triple Leaf Tea, Inc. Form 483, 2017-07-20

FDA issued a Form 483 to Triple Leaf Tea, Inc. on 2017-07-20 with 18 public-safe observations.

483· Form 483 issuedFoods & Cosmetics18 observations

Triple Leaf Tea, Inc. · Burlingame, United States · Issued July 20, 2017

Overview

  • 18 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 Jul 2017
21 CFR 111.127(d)

QC operations - packaged, labeled; specifications

Cited by Helen J Hamaoka

20 Jul 2017
21 CFR 111.127(d)

QC operations - packaged, labeled; specifications

Cited by Helen J Hamaoka

20 Jul 2017
21 CFR 111.140(b)(1)

Records - quality control operations; responsibilities

Cited by Helen J Hamaoka

20 Jul 2017
21 CFR 111.140(b)(1)

Records - quality control operations; responsibilities

Cited by Helen J Hamaoka

20 Jul 2017
21 CFR 111.155(c)

Components - quarantine

Cited by Helen J Hamaoka

Inspected site

TLTriple Leaf Tea, Inc.Burlingame, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.127(d)Cited across public-safe Form 483 observations2x
21 CFR 111.140(b)(1)Cited across public-safe Form 483 observations2x
21 CFR 111.155(c)Cited across public-safe Form 483 observations2x
21 CFR 111.205(b)(2)Cited across public-safe Form 483 observations2x
21 CFR 111.23(b)Cited across public-safe Form 483 observations2x
21 CFR 111.255(b)Cited across public-safe Form 483 observations2x
21 CFR 111.320(b)Cited across public-safe Form 483 observations2x
21 CFR 111.70(a)Cited across public-safe Form 483 observations2x
21 CFR 111.75(a)(1)(i)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 18 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere